The retailer of "all things beauty" posted Q2 net sales growth in excess of 20% to $1.29bn. Rumors have been swirling about a possible luxury beauty play from Amazon, but Ulta management is undaunted, telling investors, “We have no blinders on, and we're playing offense.”
Ulta Beauty, Inc. has been booking double-digit comparable sales growth on a quarterly basis since December 2014 and remains confident that beauty enthusiasts have made their home at the specialty retailer's e-commerce site and its more than 1,000 stores across the US.
Reported Aug. 24, Ulta's fiscal 2017 second quarter was another for competing retailers to envy, with comparable sales (those for...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
